Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference ...Middle East

PR Newswire - News
Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference
LUND, Sweden, Sept. 16, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today presented detailed model-development study results at the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer (abstract #B027)....

Hence then, the article about immunovia presents data from model development study at 2024 aacr advances in pancreatic cancer medical conference was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference )

Apple Storegoogle play

Last updated :

Also on site :